1. Home
  2. TENX vs ARL Comparison

TENX vs ARL Comparison

Compare TENX & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.79

Market Cap

317.8M

Sector

Health Care

ML Signal

N/A

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

HOLD

Current Price

$15.23

Market Cap

261.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
ARL
Founded
1967
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
261.7M
IPO Year
2001
1999

Fundamental Metrics

Financial Performance
Metric
TENX
ARL
Price
$1.79
$15.23
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
7.9M
9.2K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
206.59
EPS
N/A
N/A
Revenue
N/A
$50,014,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.70
52 Week Low
$1.31
$12.42
52 Week High
$19.40
$24.44

Technical Indicators

Market Signals
Indicator
TENX
ARL
Relative Strength Index (RSI) 19.03 46.23
Support Level $1.31 $14.71
Resistance Level $16.39 $15.83
Average True Range (ATR) 0.55 0.60
MACD -0.78 0.11
Stochastic Oscillator 3.48 31.74

Price Performance

Historical Comparison
TENX
ARL

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments: the acquisition, development, ownership and management of multifamily properties (Residential Segment) and the acquisition, ownership and management of commercial real estate properties (Commercial Segment). Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: